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ABSTRACT 
Prostate cancer is the third most common cancer among men. Risk factors for prostate cancer contain 
environmental factors such as diet rich of reactive oxygen species. Epidemiological studies recommend dietary 
consumption of plant-derived foods may decrease the risk of prostate, colon, pancreas, breast and lung cancers. 
However, it has been difficult to identify specific components responsible for this effect. Many phytochemicals have 
been shown to be biologically active compounds and they may act as a protective factor against cancer. Recent 
researches have revealed that diets based on flavonoids have the potential benefits for cancer prevention. Flavonoids 
are part of a large class of polyphenols that are found widely in diet. Nowadays, experimental researches have 
suggested developing proof for the valuable action of flavonoids on multiple cancer-related biological pathways. 
Although the outcomes of studies about flavonoids and prostate cancer are still limited and conflicting, some 
protective associations have been suggested for flavonoid-rich foods. The current review presented molecular 
mechanism of the main flavonoids on prostate cancer. The main mechanisms are in three different directions. These 
mechanisms contain antioxidant activity and inhibition of DNA damage of its oxidizing agents, anti-cell proliferation 
and induction of apoptosis. 
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1. INTRODUCTION 
Worldwide, Prostate cancer (PCa) is the sixth cancer, and the third most common cancer among men. Risk 
factors for PCa include environmental factors, age, race/ethnicity, and family history. Very few men are diagnosed 
younger than age 50, with the mean age of diagnosis in the beginning 70’s. Incidence varies widely by country and 
racial/ethnic origin. The highest rate has been achieved in western countries while the lowest rates have seen in Asian 
countries (Grönberg, 2003). Other probable risk factors include hormonal factors, body mass index, and diet. Several 
researches have proven positive associations between PCa and BMI incidence, although not all results have been 
consistent (Crawford, 2003). With the great abundance of incidence worldwide, differences in diet, especially fat 
intake, have been increasingly studied. Because the growth of the prostate is directed by androgens, these hormones 
may be another risk factor (Prins and Korach, 2008). PCa remains the most commonly diagnosed cancer and second 
leading cause of cancer mortality among men in several national groups in the United States. Lower PCa occurrence 
among Asian population has been attributed to increased intake of herbal rich diet. On the other hand, the 
environmental factors such as some diet changes the patterns of epigenetic and leading to changes in gene expression. 
Some of the genes associated with creating and advancing PCa (Labbé, 2014). Plants have been consumed as 
medicines for thousands of years (Sewell and Rafieian-Kopaei, 2014, Bahmani, 2014, Asadbeigi, 2014, Asgari, 
2012).  
Recent researches have also presented promising results in the prevention and treatment of diseases 
(Fasihzadeh, 2016, Lorigooini, 2015, Lorigooini, 2014, Heidarian and Rafieian-Kopaei, 2012). These medicines 
primarily took the form of crude drugs such as teas, powders, poultices, tinctures and other natural formulations 
(Balunas and Kinghorn, 2005, Rafieian-Kopaei and Nasri, 2014). The particular herbal drugs to be used and the 
methods of application for specific diseases were passed down via oral history. Eventually information regarding 
medicinal plants was documented in herbals. In latest history, the consumption of plants as drugs has included the 
isolation of active phytochemicals, beginning with the separation of morphine from Papaver somniferum in the early 
19th century (Kinghorn, 2001, Samuelsson, 1992). Drug finding from medicinal herbs lead to the separation of novel 
natural drugs (Balunas and Kinghorn, 2005). Isolation and characterization of pharmacologically active compounds 
from medicinal herbs continue these days (Di Carlo, 1999, Rahnama, 2015, Nasri and Rafieian-Kopaei, 2014b). One 
of these active secondary metabolites are flavonoids (Rabiei, 2015). 
Flavonoids are part of a large classes of polyphenols that are originated widely in vegetables and fruits. This 
class of secondary metabolites has been of significant medical attentiveness due to their anti-inflammatory, analgesic 
and anti-tumor activities (Asgary, 2013, Bahmani, 2014, Shayganni, 2015). Recent studies also have revealed that 
flavonoids possess medicinal specification, especially antioxidant activities. Some environmental factors are the 
cause of oxidative stress (Apel and Hirt, 2004, Mirhosseini, 2014). Oxidative stress can do extensive damage to all 
components of cells, and subsequently causing variety of diseases such as cancer. Studies have shown that oxidative 
stress can potentially lead to development of cancer. Namely, the oxidative agents cause DNA damage. DNA 
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damages can be carcinogenic (Loft and Poulsen, 1997). Today, it has been proved that some foods are natural anti-
cancer or prevent cancer agents (Ren, 2003, Samani, 2015). 
Nowadays, dietary patterns worldwide vary greatly, especially between the countries that differ widely in 
PCa incidence (Crawford, 2003, Grönberg, 2003). Studies reveal how important diet can be in PCa etiology. 
Flavonoid intake is one aspect of diet that has not been sufficiently researched. Some studies have assessed the 
relationship between cancers and flavonoid intake, but very few have examined flavonoids and PCa specifically. 
One cohort study found that get a greater degree of the flavonoid myricetin was associated with less risk of PCa  
(Knekt, 1996), while another study found no association between flavonoids and PCa (Rossi, 2010). Experimental 
data support at least a role for flavonoids in PCa progression prevention and expansion. 
Flavonoids are one of plant secondary metabolites; which are present in the foods of herbal origin as well as 
in medicinal herbs and have various medicinal effects (Sedighi, 2014, Delfan, 2014, Karimi and Moradi, 2015). They 
are categorized into flavones, flavonols, isoflavones, flavonols, flavonones, and flavononols. Currently herbal 
treatments including flavonoids are used in many areas of the world (Craig, 1999, Di Carlo, 1999, Samuelsen, 2000). 
Flavonoids are polyphenolic compounds; define chemically as substances composed of a common 
phenylchromanone structure (C6-C3-C6), with one or more hydroxyl substituents, including derivatives (Table 1). 
In marked contrast to flavonoids, isoflavonoids have a 3-phenylchroman skeleton that is biogenetically derived from 
the 2-phenylchroman skeleton of the flavonoids. Isoflavonoids are available from different family of plants. In 
mammals, flavonoids and isoflavonoids occur only through dietary intake. Isoflavonoids and Flavonoids have shown 
many biological properties that may account for cancer or other therapeutic effects (Bravo, 1998, Birt, 2001, Messina, 
1999). Today, special attention has been paid to their potential to inhibit the oxidative stress, cell proliferation, cell 
cycle, to induce detoxification, apoptosis, and the immune system. Building upon this foundation will facilitate 
development of new strategies and approaches for cancer control (Apel and Hirt, 2004).  
Table.1. Chemical structures, Classification and food sources of certain commonly dietary 
flavonoids aglycones (Kumar and Pandey, 2013). 
Dietary source Flavonoid Structure backbone Group of 
flavanoid 
Fruit skins 
red wine 
buckwheat 
red pepper 
tomato skin 
Rutin 
Luteolin 
luteolin glucosides 
O
O  
Flavones 
Onion 
red wine 
olive oil 
berries 
grapefruit 
Kaempferol 
Quercetin 
Myricetin 
tamarixetin 
O
O
OH
 
Flavonols 
Citrus fruits 
Grapefruits 
Lemons 
Oranges 
Naringin 
Naringenin 
Taxifolin 
Hesperidin 
O
O  
Flavanones 
 
- 
 
- 
O
O
OH
 
Flavanonol 
Soyabean Genistin 
daidzin 
O
O  
Isoflavones 
Tea (+)-Catechin 
(−)-Epicatechin 
Epigallocatechin 
Chrysin apigenin 
O
O
OH
 
Flavan-3-ols 
Cherry 
Easberry 
Strawberry 
Anthocyanidin 
cyanidin 
O
O  
Flavones 
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Although widespread attempt has been made to recognize the biological effects responsible for the 
chemopreventive activity of these compounds, the accurate molecular mechanisms involved are not fully understood. 
Anyway, researchers have found there is a deep connection between the defect detoxification and cancer (Liska, 
1998). For example, it has already been established that the oxidative stress can increase the level of Akt expressed 
within cells. The overexpression of Akt can lead to development of cancer (Yang, 2006). One of the most vital 
functions of natural products in prevention or inhibition of cancer is detoxification and elimination of free radicals 
(Lobo, 2010). 
Briefly, different flavonoids are safe natural compounds that with diverse mechanisms can carry out their 
anti-cancer roles. For example, it has been found that some flavonoids have potential as a complementary therapy in 
PCa. In contrast the various molecular mechanisms involved in carcinogenesis and cancer progression. Therefore, in 
this review presented the main known anti-cancer mechanisms of flavonoids. It is clear that finding effective 
flavonoids also detection of their molecular mechanisms is essential to create synergistic effects that can be used to 
reduce the dose of chemotherapy drugs and their side effects and better treatment effects. 
Mechanisms and Discussion: Some studies showed that South East Asian countries have a much lower risk of 
prostate, breast, colon and other cancers than their Western counterparts (Dorai and Aggarwal, 2004), and it is 
thought that their diet may have significant function in protection. The Phenolic compounds are in fruit and 
vegetables, and in medicinal herbs, have chemo-preventive activities in tumors (Surh, 1999, Mahmoud, 2000). 
Flavonoids have been linked with a reduced risk of digestive tract, lung and certain hormone-related cancers (Bosetti, 
2006). Epidemiologic researches have shown an inverse association between high flavonoid intake in men and low 
PCa risk. Diet of East Asian have very rich in flavonoids and, correspondingly, men in these countries have the 
lowest incidence of PCa (Haddad, 2006). For anti-cancer flavonoids roll was known different molecular mechanisms. 
The main mechanisms are in three different classes. These mechanisms contain antioxidant activity and prevent 
damage to DNA of its oxidizing agents, inhibition of cell proliferation and induction of apoptosis (Hertzogi and Tica, 
2012). 
Flavonoids may play their anti-oxidant and anti-inflammatory roles via direct inhibition of prooxidant 
enzymes (Rafieian-Kopaei, 2013b, Baradaran and Rafieian-kopaei, 2014). The antioxidant activity is usually 
performed through the direct removal of the free radicals (Nasri and Rafieian-Kopaei, 2014a, Rafieian-Kopaei, 
2013a, Nasri and Rafieian-Kopaei, 2013). Formation of ROS (reactive oxygen species) is a major step in stages of 
tumor progression. NADPH oxidase I (NOX 1), is down expressed during tumor growth (Fukuyama, 2005, Lim, 
2005, Arnold, 2007). ROS is mutagenic and play important role in DNA damage (Poli, 2004, Valko, 2004). Liu and, 
showed that ROS could induce and increase cell proliferation, apoptosis resistance, and overexpression of some 
oncogenes such as cFOS, cJUN and cMyc (Liu, 2002). Some flavonoids inhibit ornithine decarboxylase enzyme that 
induced by tumor promoters, and thereby inhibiting proliferation (Dangles, 2006, Sandhar, 2011). The flovonoids 
interact with the pathways signaling cell growth and apoptosis (Khan, 2015). Knekt and, estimated that men with 
higher myricetin intake had a lower PCa incidence (Knekt, 1996). Many flavonoids that tested in vitro exerted anti 
proliferative effect in the some cell lines of PCa compared to the non-PCa cells. As an example, PC3 cell line was 
arrested in cell cycle (Haddad, 2006). The flavonoids targets are some regulator proteins in cell cycle such as CDKs 
and their inhibitors, p53, E2Fs, Rb, ATM/ATR and stay in transition-control points G1/S and G2/M (Singh and 
Agarwal, 2006). Dalu, have shown that in male rats  genistein decreases the amount of prostate EGF (Epidermal 
Growth Factor) receptor. Genistein may be effect on expression or turnover of receptor of EGF (Lamartiniere, 2000, 
Peterson and Barnes, 1993). The growth factor hormones are connected to extracellular domains of receptors. These 
receptors display a tyrosine kinase (TK) activity in their intracellular portion. After hormone–receptor binding, the 
receptor, then triggering a substantial number of signaling pathways involving some PKs, for example, PKC, and 
MAPKs (mitogen-activated PKs) (Batra and Sharma, 2013). In cell cycle, DNA replication and chromosomes built 
is controlled by cyclin-dependent kinases (CDKs) phosphorylation. Flavonoids inhibit some PKs, so inhibit cell 
proliferation. Also, Lutein appears as a specific inhibitor of TKs (Yang, 1998, Yang, 2006). Quercetin was induced 
some tumor suppressor genes expression (TS). Beside, quercetin inhibited the expression of some oncogenes 
expression and control gene in phases of the cell division cycle significantly. The achievements of researches 
provided an important potential for use of some flavonoids in the chemoprevention of cancers (Nair, 2004; Azadmehr 
, 2011 ).  
2. CONCLUSION 
According to the various results of studies in this area seems moreover chemotherapy drugs, flavonoids 
might be beneficial in the cancer treatment or inhibition (Hertzogi and Tica, 2012). Flavonoids induce apoptosis 
mechanisms in cancer cells. Polyphenols activate cell-death signalling pathways and stimulate apoptosis in cells 
before they become cancerous. Finally inhibit cancer development or progression (Hertzogi and Tica, 2012).  
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